ArticleLamivudine: An antiviral drug with high risk factor for selection of resistance in HBV patients
ArticleLamivudine: An antiviral drug with high risk factor for selection of resistance in HBV patients
ArticleFulminant hepatitis by concurrent acute HBV-HCV infection successfully treated with antivirals while seeking for an orthotopic liver transplantation
ArticleFulminant hepatitis by concurrent acute HBV-HCV infection successfully treated with antivirals while seeking for an orthotopic liver transplantation
ArticleOutcome of Hepatitis B treatment with oral drugs (Tenofovir and Entecavir) in a tertiary care center in eastern India
ArticleOutcome of Hepatitis B treatment with oral drugs (Tenofovir and Entecavir) in a tertiary care center in eastern India
ArticleHepatitis B Surface Antigen Quantitation as a Predictor of Treatment Response in Chronic Hepatitis B
ArticleHepatitis B Surface Antigen Quantitation as a Predictor of Treatment Response in Chronic Hepatitis B
ArticleEfficacy and safety of Tenofovir Disoproxil Fumarate in Egyptian patients with chronic hepatitis B virus infection
ArticleEfficacy and safety of Tenofovir Disoproxil Fumarate in Egyptian patients with chronic hepatitis B virus infection
ArticleEfficacy and safety of Tenofovir Disoproxil Fumarate in Patients with Chronic Hepatitis B with High Baseline Viral Load
ArticleEfficacy and safety of Tenofovir Disoproxil Fumarate in Patients with Chronic Hepatitis B with High Baseline Viral Load
ArticleA Retrospective- Prospective Study for the Efficacy and Safety of Entecavir in a Cohort of West Asian with Chronic HBV Infection
ArticleA Retrospective- Prospective Study for the Efficacy and Safety of Entecavir in a Cohort of West Asian with Chronic HBV Infection
ArticleLiver histopathology detects more chronic hepatitis B virus genotype D patients who need to be treated
ArticleLiver histopathology detects more chronic hepatitis B virus genotype D patients who need to be treated
ArticleResponse to Hepatitis B Vaccine in Chronic Hepatitis C Patients Treated with Direct Acting Antivirals
ArticleResponse to Hepatitis B Vaccine in Chronic Hepatitis C Patients Treated with Direct Acting Antivirals